Society5 years ago
AstraZeneca has joined Oxford scientists to trial vaccine
Cobra Biologics, Oxford scientists and AstraZeneca aim to make a million COVID-19 vaccine doses a month available for trials, with a view to building stocks for commercial supply when the vaccine is eventually approved.